About

Amir Genosar is Chief Executive Officer and Co-Founder of Aktiv Pharma Group. In 2006, Mr Genosar co-founded SteadyMed (acquired by United Therapeutics in 2018), and was an inventor of its drug-device combination product patch pump. During his career he has helped several companies innovate and address unmet needs in the drug delivery device space including, Johnson & Johnson, Novartis, Philips, and Medtronic. He is an inventor of the MAP Pharmaceutical combination product inhaler technology (acquired by Allergan in 2013). Prior to his innovation and entrepreneurship career Mr Genosar held manufacturing positions for drug delivery devices.

Contributions

INJECTION

PRODUCT SHOWCASE: Aktiv Pharma’s ARAI Autoinjector Platform

Aktiv Pharma showcases its ARAI autoinjector platform, which is powered by pressurised CO₂ and incorporates the company's proprietary glass-free flexible primary container made from high-barrier films, in a form of blister package, named ARCH.